A new class of synthetic opioids known as nitazenes is drawing urgent attention from public health and addiction experts as the U.S. drug supply becomes increasingly unpredictable and lethal. Recent reporting from STAT and Bellingcat says nitazenes are spreading rapidly across the country and, in some forms, may be up to 40 times more potent than fentanyl. The investigation found that 48 of 50 states have reported nitazene seizures, underscoring how quickly these substances are moving into the illicit market.
Nitazenes were first developed in the 1950s for pharmaceutical research but were never approved for medical use in the United States or elsewhere. The DEA says these compounds can match or exceed fentanyl’s potency and are often mixed with fentanyl or other drugs, making overdose risk even harder to predict. Because nitazenes typically cannot be identified without laboratory testing, people may not know they are being exposed until it is too late.
Recent reporting also indicates that overdose deaths involving nitazenes have risen sharply in the U.S., with confirmed deaths climbing from 27 in 2020 to 409 in 2024. For healthcare leaders, pharmacists, policymakers, and addiction professionals, the rise of nitazenes highlights the need for stronger drug-supply surveillance, expanded overdose prevention, and continued investment in evidence-based addiction treatment. As the synthetic opioid crisis evolves beyond fentanyl alone, nitazenes are likely to become a growing focus in conversations about public health response, toxicology, and community readiness.
Read More: https://www.statnews.com/2026/06/18/nitazenes-deadly-synthetic-opioids-rapid-spread-united-states/